Pay with crypto — save 10%
  • Janoshik Verified
  • Same-day dispatch by 4 PM EST
  • Free shipping over $250
  • Made & shipped from Canada

Superdrol vs Anadrol: The Two Strongest Oral Steroids Head-to-Head

Superdrol vs Anadrol compared: gains, liver toxicity, side effects & cycle protocols. Which strongest oral steroid fits your goals? Full breakdown.

Nova Pharma Research Team

Editorial & Scientific Research

18 min read
superdrol vs anadrolstrongest oral steroidsuperdrol or anadrolmethyldrostanolone vs oxymetholone

Ask any experienced bodybuilder which oral steroid produces the most brutal, scale-moving, strength-shattering gains and you will hear two names: Superdrol and Anadrol. These are not "starter" orals like Dianabol or Turinabol. They are the heavyweights — the compounds that turn a stalled bulk into a 15-pound month and turn a routine cycle into a liver-function emergency if you treat them carelessly.

This comparison is written from a harm-reduction standpoint. Both of these compounds are 17-alpha-alkylated oral steroids, and both carry documented cases of cholestatic liver injury and renal failure in the medical literature. Nasr and Ahmad's 2009 report on Superdrol-induced severe cholestasis and renal failure, and the Jasiurkowski case of cholestatic jaundice plus IgA nephropathy, are not theoretical risks — they are people who took these exact compounds and ended up in a hepatology ward. Nothing in this article should be read as encouragement to use either substance. The goal is to make sure that anyone who does is the most informed person in the room about what they are actually putting their liver through.

Pharmacological Profiles

Superdrol (Methyldrostanolone / Methasterone)

  • Classification: DHT-derived anabolic steroid (methylated drostanolone)
  • Anabolic rating: 400
  • Androgenic rating: 20
  • Half-life: ~8 hours (oral)
  • Detection time: 3-4 weeks
  • Hepatotoxicity: Very high (17-alpha-alkylated, no ester to soften the hepatic load)
  • Aromatization: None
  • First marketed: ~2005 as a "designer" prohormone supplement, before regulatory bans
  • Medical uses: None — never approved as a pharmaceutical; existed only as a grey-market "supplement"

Anadrol (Oxymetholone)

  • Classification: DHT-derived anabolic steroid (2-hydroxymethylene-modified)
  • Anabolic rating: 320
  • Androgenic rating: 45
  • Half-life: ~8-9 hours (oral)
  • Detection time: ~8 weeks
  • Hepatotoxicity: High (17-alpha-alkylated)
  • Aromatization: None — yet produces strong estrogenic effects through a non-aromatase pathway (see below)
  • First synthesized: 1960 (Syntex)
  • Medical uses: Anemia (including aplastic anemia), HIV/AIDS wasting, osteoporosis — still a legitimately prescribed drug (Pavlatos et al. reviewed its clinical pharmacology in detail)

The single most important structural distinction: Superdrol is methylated drostanolone, a compound with essentially zero estrogenic machinery, so its weight gain is dry and lean. Anadrol, despite not aromatizing, behaves like a wet, estrogenic drug clinically — the "Anadrol paradox" that catches so many users off guard.


Head-to-Head Comparison

ParameterSuperdrolAnadrol
Raw mass gain (scale)+++++++++
Lean/dry quality of gain+++++++
Strength increase++++++++++
Water retentionNone (very dry)High (very wet)
Estrogenic side effectsNoneHigh (paradoxical)
Liver toxicity+++++++++
Lipid disruption+++++++++
"Lethargy / malaise" reportsHighModerate
AppetiteOften suppressesOften suppresses (or kills it)
Androgenic sides+++++
Blood pressure impact+++++++++
Pump / fullnessModerateExtreme (sometimes painful)
Typical cycle length3-4 weeks4-6 weeks
Typical male dose10-20 mg/day50-100 mg/day
Counterfeit riskModerateModerate

Both compounds sit at the very top of the oral-steroid toxicity ranking — in the comparative liver-toxicity hierarchy that appears across the harm-reduction literature, Superdrol and Anadrol rank just below methyltestosterone and Halotestin, and well above Dianabol, Winstrol, or Anavar. There is no version of "running these safely." There is only running them less dangerously.


Gains Profile: Dry Power vs Wet Mass

This is where the two compounds genuinely diverge, and where choosing between them actually means something.

Superdrol: Dry, Hard, Deceptively Lean

Superdrol is methylated drostanolone, and drostanolone (Masteron) is the archetypal "hardening" steroid. That heritage carries through. Superdrol produces:

  • Lean, dry weight gain — typically 8-15 lbs over a short cycle, most of it appearing as denser, harder muscle rather than bloat
  • Rapid strength gains — many users report personal records within the first 10-14 days
  • A "filled out but dry" look — vascularity often improves rather than disappears under water
  • No estrogenic bloat — because there is no estrogenic activity, the scale weight is more "real" than Anadrol's

The catch is that Superdrol's gains come with a notoriously heavy subjective cost. Lethargy, loss of appetite, dark moods, and a general "run down" feeling are extremely common — Llewellyn's Anabolics documents these as near-universal complaints. Many people cannot tolerate Superdrol past two weeks not because of bloodwork but because they simply feel terrible.

Anadrol: Maximal Scale Weight, Maximal Bloat

Anadrol moves the scale faster than almost anything in oral form. Users commonly report 15-25 lbs over a 4-6 week run — but a large fraction of that is water and glycogen. The Anadrol look is:

  • Massive, full, "puffy" mass — muscles look swollen, sometimes smoothed over
  • Insane pumps — to the point of being painful in the lower back and forearms during training
  • Explosive strength — Anadrol is a legendary powerlifting and strongman compound for raw force
  • A dramatic but partly illusory transformation — drop the drug and 5-10 lbs of water leaves within a week

For a competitor trying to fill out before a peak week, or a strength athlete chasing a one-rep max, Anadrol's water can be an asset. For someone who wants gains they get to keep, Superdrol's drier profile retains more after the cycle ends.


The Anadrol Estrogenic Paradox

This deserves its own section because it confuses even intermediate users.

Anadrol does not aromatize. It is a DHT derivative — there is no chemical pathway for it to convert to estradiol. And yet Anadrol reliably produces classic estrogenic side effects: water retention, elevated blood pressure, and, critically, gynecomastia. Isaacs et al. documented a clear case of oxymetholone-induced gynecomastia, the smoking gun for this paradox.

The accepted explanation is that oxymetholone acts as a direct agonist at the estrogen receptor itself — it is "estrogenic" not by becoming estrogen, but by directly stimulating estrogen receptors in tissue. This has a brutal practical consequence:

Aromatase inhibitors do not fully work against Anadrol's estrogenic effects. Arimidex, Aromasin, and Letrozole work by blocking the enzyme that converts androgens to estrogen. But Anadrol's estrogenic action bypasses that enzyme entirely. You can run a full dose of an AI and still develop gyno on Anadrol because the drug is hitting the receptor directly. The only reliable defense is a SERM (selective estrogen receptor modulator) like tamoxifen (Nolvadex) or raloxifene, which blocks the receptor itself rather than the enzyme.

This is the single most important safety fact that separates Anadrol from every other non-aromatizing steroid. If you take Anadrol expecting AI-only estrogen control, you will be unprotected. Superdrol, by contrast, has no estrogenic activity of any kind — gyno is a non-issue on Superdrol.


Hepatotoxicity: The Defining Risk of Both

Both compounds are 17-alpha-alkylated. That methyl group at the 17th carbon is what lets the molecule survive first-pass liver metabolism and reach the bloodstream orally — and it is exactly what makes the liver pay. Bond, Llewellyn and Van Mol's review of anabolic-androgenic steroid hepatotoxicity frames the mechanism clearly: 17-alpha-alkylated orals interfere with bile flow (cholestasis), can trigger oxidative stress in hepatocytes, and at the extreme produce peliosis hepatis — blood-filled cysts in the liver, a phenomenon Cabasso documented in a young bodybuilder.

Superdrol's Hepatic Record

Superdrol is one of the most documented hepatotoxic oral steroids in the medical literature precisely because it was sold openly as a "supplement," so people took it without any of the harm-reduction context a black-market user might have:

  • Nasr and Ahmad reported a case of severe cholestasis and renal failure directly attributed to methasterone (Superdrol) — not just elevated enzymes, but cholestatic jaundice plus kidney involvement requiring medical intervention.
  • Jasiurkowski et al. documented cholestatic jaundice and IgA nephropathy in a user of the same OTC "muscle building agent," again coupling liver injury with renal damage.
  • Kafrouni, Anders and Verma reviewed hepatotoxicity from dietary supplements containing anabolic steroids — Superdrol-type designer steroids feature prominently in this category of "supplement" liver injury.

The pattern in these case reports is consistent and alarming: jaundice (yellowing of skin and eyes), dark urine, pale stools, profound fatigue, and itching — the classic cholestatic presentation — often appearing only 3-4 weeks in, sometimes after the user has already stopped. The injury can progress after cessation.

Anadrol's Hepatic Record

Anadrol is also seriously hepatotoxic, though its longer history as a prescription drug means its risks were characterized in a clinical setting. Pavlatos et al.'s clinical review notes hepatic dysfunction as a recognized adverse effect, and the broader literature documents cholestasis, peliosis hepatis, and even hepatocellular tumors with long-term high-dose use in patients. Anadrol's hepatotoxicity is dose- and duration-dependent — the anemia and wasting patients who developed liver tumors were on it for months, not weeks.

Which Is Worse?

On a milligram-for-milligram basis, Superdrol is generally considered the more aggressively hepatotoxic of the two — which is why effective doses are an order of magnitude lower (10-20 mg vs 50-100 mg). But the practical risk converges: both can cause clinically significant, occasionally permanent liver injury, and both have put users in the hospital. The Bond/Llewellyn/Van Mol analysis emphasizes that individual susceptibility varies enormously — some people show minimal enzyme elevation, others develop cholestasis on a "normal" dose. You cannot know which you are until it is happening.

Hard rules for either compound:

  • Never run either for longer than 4-6 weeks (Superdrol: 3-4 weeks is safer)
  • Never run them stacked with another 17-alpha-alkylated oral
  • Zero alcohol for the entire cycle and for weeks afterward
  • TUDCA 500-1000 mg/day is considered mandatory, not optional, by harm-reduction practitioners
  • Stop immediately at any sign of jaundice, dark urine, pale stools, right-upper-quadrant pain, or unexplained itching — these are cholestasis warning signs, not "push through it" symptoms

Bloodwork: Non-Negotiable for Both

If there is one compound class where pre-, mid-, and post-cycle bloodwork crosses from "good practice" into "the only responsible way to use it," this is it. See our bloodwork guide for steroid users for the full panel breakdown.

For Superdrol or Anadrol specifically, the priority markers are:

  • Liver enzymes (ALT, AST): Expect elevation. Mild-to-moderate rises (up to ~3x) are common; anything beyond that, or any rise accompanied by symptoms, means stop. GGT and bilirubin matter more than ALT/AST for catching cholestasis specifically, because cholestatic injury can spike bilirubin while transaminases stay deceptively modest.
  • Bilirubin (total and direct): This is the marker that actually catches the cholestatic pattern documented by Nasr/Ahmad and Jasiurkowski. Rising bilirubin = the liver is failing to clear bile. Do not ignore it.
  • Lipid panel (HDL, LDL): Both compounds devastate lipids — HDL can crash by 50-70%, LDL climbs sharply. Hartgens and Kuipers' review of androgenic-anabolic steroid effects in athletes documents these lipid shifts as among the most consistent and concerning systemic effects.
  • Kidney function (creatinine, eGFR, urinalysis): The renal failure and IgA nephropathy in the Superdrol case reports make this non-optional for Superdrol in particular.
  • Blood pressure: Not a blood test, but check it daily. Anadrol especially drives blood pressure up via water retention.

A reasonable schedule: baseline before starting, a mid-cycle check at week 2-3 (the window when the case-report jaundice tends to appear), and a follow-up 4-6 weeks after stopping to confirm recovery.


Dosing and Protocol (Research Framing)

The doses below reflect what appears in the harm-reduction and bodybuilding literature. They are presented for harm-reduction completeness, not as a recommendation to use controlled substances.

Superdrol

ExperienceDoseDurationNotes
Cautious10 mg/day3-4 weeksMany users feel maximal effect here; higher doses mostly add toxicity
Standard20 mg/day3-4 weeksUpper end of a defensible dose
Reckless30 mg+/daySharply escalating hepatic risk for marginal gain

Anadrol

ExperienceDoseDurationNotes
Cautious25-50 mg/day4-6 weeksOften as effective as higher doses; appetite is a limiter
Standard50 mg/day4-6 weeksThe classic "Anadrol 50" dose
Aggressive75-100 mg/day4 weeksDiminishing returns, steep blood-pressure and liver cost

Both compounds should be run only on top of a testosterone base — they suppress natural testosterone production hard, and neither aromatizes (Superdrol not at all; Anadrol not via aromatase), so a separate testosterone source maintains baseline androgen function and libido. A proper PCT after the cycle is essential. For the recovery side, see the complete PCT guide, and for Anadrol-specific mass protocols, the Anadrol cycle for mass guide goes deeper.

Because Anadrol's estrogenic action is receptor-mediated, keep a SERM (Nolvadex/raloxifene) on hand for the entire Anadrol cycle — an AI alone will not protect you (see the paradox section above). For Superdrol, no estrogen management is needed at all.


Harm Reduction: If You Are Going to Do This Anyway

  • Pick one, never both. Stacking two of the most hepatotoxic orals in existence is how case reports get written.
  • TUDCA, not "liver support" multivitamins. Milk thistle and NAC are adjuncts; TUDCA (a bile acid) directly addresses the cholestatic mechanism these drugs trigger.
  • Keep the cycle genuinely short. The Nasr/Ahmad and Jasiurkowski injuries appeared in weeks, not months. Time on drug is the biggest modifiable risk factor.
  • Treat jaundice as an emergency. Yellow eyes, dark urine, itching — stop the drug and get to a doctor. Cholestasis can worsen after cessation.
  • Source matters. Both are counterfeited or under/over-dosed. A bottle labeled "Superdrol 10 mg" containing 25 mg is a liver injury waiting to happen. Insist on tested product and a Certificate of Analysis.
  • Blood pressure is the silent killer. Anadrol in particular can push BP into hypertensive-crisis territory through water retention. Monitor daily; have a plan to drop the dose or stop.

Frequently Asked Questions

Which is stronger, Superdrol or Anadrol?

For raw scale weight, Anadrol wins — 15-25 lbs is common, though much of it is water. For dry, lean, retained muscle, Superdrol wins. For pure strength, it is close to a tie; both are elite strength drugs, with Anadrol's edge in powerlifting/strongman circles coming partly from the supportive water and pumps. "Stronger" depends entirely on whether you mean the number on the scale or the quality of what stays after the cycle.

Why do I get gyno on Anadrol if it doesn't aromatize?

Because oxymetholone acts directly on the estrogen receptor rather than converting to estrogen. Isaacs et al. documented exactly this — gynecomastia from a non-aromatizing drug. The practical consequence is that aromatase inhibitors (Arimidex, Aromasin) do not reliably protect you, because they block estrogen production, not the receptor. You need a SERM like tamoxifen, which blocks the receptor itself. This is the most commonly misunderstood fact about Anadrol.

Can I use an aromatase inhibitor to control Anadrol bloat?

Only partially. An AI can help with any estrogenic activity from your testosterone base, but it will not stop Anadrol's own receptor-mediated effects, including gyno. For water retention specifically, the more effective levers are keeping the dose moderate, controlling sodium, and limiting duration. For gyno protection, a SERM is the answer, not an AI.

How toxic to the liver are these really — is the danger overstated?

It is not overstated. These are not "elevated enzymes that normalize" drugs at the extreme end — the medical literature contains documented cases of cholestatic jaundice, renal failure, and IgA nephropathy from Superdrol (Nasr & Ahmad; Jasiurkowski et al.) and peliosis hepatis and hepatocellular tumors from long-term Anadrol. Most users get away with transient enzyme elevation, but a meaningful minority do not, and you cannot predict which group you are in. Bilirubin and symptoms (jaundice) matter more than ALT/AST for spotting the dangerous cholestatic pattern.

How long can I safely run Superdrol or Anadrol?

"Safely" is the wrong word for either, but the harm-reduction ceiling is short: Superdrol is best capped at 3-4 weeks, Anadrol at 4-6 weeks. The case-report liver injuries appeared within this window, sometimes worsening after the user stopped. Longer is not "more gains" — it is "more cholestasis risk" for diminishing benefit.

Do I need a testosterone base with these orals?

Yes. Both suppress your natural testosterone production sharply. Running them alone leaves you hypogonadal — low libido, fatigue, erectile dysfunction, mood crashes — for the duration plus recovery. A testosterone base (typically a TRT-range dose) maintains androgen function, and a proper PCT afterward helps your own production restart.


Conclusion: Two Different Kinds of "Strongest"

Superdrol and Anadrol are both at the apex of oral steroid potency, but they are not interchangeable, and the choice comes down to what kind of gain you want and which risks you are willing to manage.

Lean toward Superdrol if:

  • You want dry, hard, retainable mass without water bloat
  • You have no tolerance for estrogenic side effects (gyno, water, blood pressure)
  • You can stomach the lethargy and malaise it commonly causes
  • You will keep the cycle to 3-4 weeks and watch bilirubin closely

Lean toward Anadrol if:

  • You want maximal scale weight and explosive pumps and strength
  • You are a strength athlete who benefits from the supportive water
  • You understand and will manage the estrogenic paradox with a SERM, not just an AI
  • You will monitor blood pressure daily

But the honest conclusion is that for most people, the better answer is neither. These are the two compounds most likely to land you in a hepatology consult. If your goals can be met with a milder oral like Anavar or Turinabol, or with an injectable that bypasses first-pass liver metabolism, those are dramatically safer roads to a similar destination. The documented cholestasis and renal failure in the Superdrol literature, and Anadrol's hospital-tier liver and cardiovascular risks, are not edge cases — they are the predictable tail of using the strongest, most hepatotoxic orals ever made. If you proceed anyway, do it short, do it solo, do it with TUDCA and a SERM and real bloodwork, and treat any sign of jaundice as the emergency it is.

Superdrol Anadrol Bloodwork for Steroid Users: The Complete Panel Guide Anadrol Cycle for Mass: Protocol Guide


Disclaimer: This article is for educational and informational purposes only. Anabolic steroids are controlled substances in Canada under the Controlled Drugs and Substances Act. Possession without prescription is illegal. Consult a healthcare professional before using any performance-enhancing compound.

References

  1. Jasiurkowski B, et al. Cholestatic jaundice and IgA nephropathy induced by OTC muscle building agent superdrol. Am J Gastroenterol. 2006;101(11):2659-2662.
  2. Llewellyn W. Anabolics. 11th ed. Molecular Nutrition; 2017.
  3. Pavlatos AM, et al. Oxymetholone: a review of its clinical pharmacology and therapeutic use. Clin Ther. 2001;23(6):789-801.
  4. Isaacs RD, et al. The estrogenic effects of oxymetholone: a case of gynecomastia. Endocr Pract. 2011;17(3):e77-e80.
  5. Nasr J, Ahmad J. Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasterone). Dig Dis Sci. 2009;54(5):1144-1146.
  6. Cabasso A. Peliosis hepatis in a young adult bodybuilder. Med Sci Sports Exerc. 1994;26(1):2-4.
  7. Schroeder ET, et al. Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab. 2004;89(10):4863-4872.
  8. Kafrouni MI, Anders RA, Verma S. Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clin Gastroenterol Hepatol. 2007;5(7):809-812.
  9. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-554.
  10. Bond P, Llewellyn W, Van Mol P. Anabolic androgenic steroid-induced hepatotoxicity. Med Hypotheses. 2016;93:150-153.
Research chemical disclaimer

All compounds discussed and sold through Nova Pharma are intended strictly for laboratory and in-vitro research purposes. Products are not for human or animal consumption, not for use in food, cosmetics, or medicinal applications, and not for any therapeutic or diagnostic use.

The information on this page is provided for educational context and documents findings from published research. It is not medical advice, not a recommendation, and not a suggestion that any compound be used outside of a controlled research environment. Consult a qualified healthcare professional for any medical or health-related decision.

By purchasing, you confirm you are a qualified researcher, accept full responsibility for proper handling and disposal, and agree to use compounds in compliance with all applicable local, provincial, and federal laws.